Laddar...

Predictive Biomarkers of Antiangiogenic Therapy for Advanced Hepatocellular Carcinoma: Where Are We?

Antiangiogenic therapy, especially treatment with sorafenib, is the primary treatment for patients with advanced hepatocellular carcinoma (HCC). However, the efficacy of such therapy is modest, with low objective response rates and limited prolongation of survival times. Several researchers have inv...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Shao, Yu-Yun, Hsu, Chih-Hung, Cheng, Ann-Lii
Materialtyp: Artigo
Språk:Inglês
Publicerad: S. Karger AG 2013
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740718/
https://ncbi.nlm.nih.gov/pubmed/24159601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343845
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!